Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

astrazeneca limited - candesartan cilexetil 32mg;  ;   - tablet - 32 mg - active: candesartan cilexetil 32mg     excipient: carmellose calcium ferrous oxide hyprolose lactose monohydrate macrogol 8000 magnesium stearate maize starch - treatment of hypertension

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

astrazeneca limited - candesartan cilexetil 4mg;  ;   - tablet - 4 mg - active: candesartan cilexetil 4mg     excipient: carmellose calcium hyprolose lactose monohydrate macrogol 8000 magnesium stearate maize starch purified water - treatment of hypertension

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

astrazeneca limited - candesartan cilexetil 8mg;  ;   - tablet - 8 mg - active: candesartan cilexetil 8mg     excipient: carmellose calcium ferrous oxide hyprolose lactose monohydrate macrogol 8000 magnesium stearate maize starch purified water - treatment of hypertension

Irlande - anglais - HPRA (Health Products Regulatory Authority)

b & s healthcare - candesartan cilexetil - tablets - 16 milligram

Singapour - anglais - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - candesartan cilexetil - tablet - 16 mg - candesartan cilexetil 16 mg

Singapour - anglais - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - candesartan cilexetil - tablet - 4 mg - candesartan cilexetil 4 mg

Singapour - anglais - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - candesartan cilexetil - tablet - 8 mg - candesartan cilexetil 8 mg

États-Unis - anglais - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - candesartan cilexetil 16 mg - atacand hct is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with atacand hct. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blo

Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astrazeneca sdn. bhd. - candesartan cilexetil; hydrochlorothiazide -

Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astrazeneca sdn. bhd. - candesartan cilexetil -